PFE Pfizer Inc. Stock Quote

PFE [NYSE]

Healthcare | Drug Manufacturers - General | USA

Index	S&P 500	P/E	11.92	EPS (ttm)	4.43	Insider Own	0.04%	Shs Outstand	5.62B	Perf Week	4.36%
Market Cap	286.41B	Forward P/E	9.92	EPS next Y	5.33	Insider Trans	-11.14%	Shs Float	5.54B	Perf Month	9.87%
Income	25.42B	PEG	-	EPS next Q	1.95	Inst Own	69.40%	Short Float	1.23%	Perf Quarter	11.26%
Sales	92.37B	P/S	3.10	EPS this Y	233.60%	Inst Trans	0.95%	Short Ratio	2.43	Perf Half Y	4.09%
Book/sh	14.67	P/B	3.60	EPS next Y	-21.53%	ROA	14.00%	Target Price	59.33	Perf Year	32.83%
Cash/sh	4.41	P/C	11.99	EPS next 5Y	-0.80%	ROE	32.70%	52W Range	38.47 - 61.71	Perf YTD	-10.45%
Dividend	1.60	P/FCF	12.47	EPS past 5Y	27.40%	ROI	18.90%	52W High	-13.60%	Beta	0.72
Dividend %	3.03%	Quick Ratio	1.10	Sales past 5Y	9.00%	Gross Margin	60.40%	52W Low	38.57%	ATR	1.46
Employees	79000	Current Ratio	1.40	Sales Q/Q	76.80%	Oper. Margin	30.30%	RSI (14)	63.41	Volatility	2.64% 3.02%
Optionable	Yes	Debt/Eq	0.44	EPS Q/Q	58.80%	Profit Margin	27.00%	Rel Volume	0.79	Prev Close	52.88
Shortable	Yes	LT Debt/Eq	0.43	Earnings	May 03 BMO	Payout	35.30%	Avg Volume	27.96M	Price	53.31
Recom	2.30	SMA20	6.69%	SMA50	3.78%	SMA200	6.94%	Volume	16,636,654	Change	0.82%

May-23-22

Initiated

SVB Leerink

Mkt Perform

$55

Apr-06-22

Resumed

Morgan Stanley

Equal-Weight

$55

Jan-05-22

Upgrade

BofA Securities

Neutral → Buy

$59 → $70

Jan-03-22

Reiterated

Bernstein

Mkt Perform

$44 → $65

Dec-20-21

Reiterated

Cowen

Outperform

$56 → $70

Dec-17-21

Initiated

Goldman

Neutral

$51

Dec-13-21

Upgrade

UBS

Neutral → Buy

$52 → $60

Dec-09-21

Initiated

Wells Fargo

Overweight

$60

Nov-19-21

Initiated

BMO Capital Markets

Outperform

$60

Jul-27-21

Resumed

Truist

Buy

$43

May-06-21

Downgrade

Mizuho

Buy → Neutral

$42

Apr-07-21

Resumed

RBC Capital Mkts

Sector Perform

$42

Feb-04-21

Upgrade

DZ Bank

Hold → Buy

$41

Dec-16-20

Downgrade

RBC Capital Mkts

Outperform → Sector Perform

$43 → $42

Nov-19-20

Resumed

Goldman

Neutral

$40

Nov-10-20

Resumed

Bernstein

Mkt Perform

$42

Oct-12-20

Downgrade

Atlantic Equities

Overweight → Neutral

$44 → $39

Sep-29-20

Initiated

Berenberg

Hold

$38

Jun-16-20

Initiated

SVB Leerink

Mkt Perform

$40

Feb-27-20

Upgrade

Standpoint Research

Hold → Buy

May-24-22 11:48AM	Pfizer's Nearly $7 Billion Acquisition Of Arena Pharma Just Paid Off In A Big Way Investor's Business Daily
11:30AM	Ocugen (OCGN) Covaxin Studies Clinical Hold Lifted by FDA Zacks
11:21AM	U.S. CDC recommends re-isolation if COVID recurs after taking Pfizer's pill Reuters
11:13AM	Biogen Needs a New CEO. Here Are Some Options. Barrons.com
09:58AM	FDA panel to review Pfizer and Moderna vaccines for children aged six month to 4 years on June 15 MarketWatch
09:47AM	Biohaven's (BHVN) Zavegepant NDA for Migraine Accepted by FDA Zacks
09:26AM	Pfizer & BioNTech COVID Jab Booster Effective in Kids Under 5 Zacks
09:00AM	Pfizer Inc. (PFE) Is a Trending Stock: Facts to Know Before Betting on It Zacks
08:52AM	Pfizer's Ulcerative Colitis Candidate Shows Remission In Over 30% Of Patients In Pivotal Studies Benzinga
08:36AM	10 High-Yield Dividend Stocks Popular on Robinhood Insider Monkey
07:22AM	Pfizer reports more positive clinical data for its investigational colitis drug MarketWatch
06:45AM	Pfizer ulcerative colitis drug leads to remission in a third of patients -study Reuters
06:45AM	Pfizer Presents ELEVATE Pivotal Findings Demonstrating Etrasimods Potentially Best-in-Class Profile in Ulcerative Colitis Business Wire
06:45AM	Pfizer Gives Encouraging Treatment Data for New Drug from Arena Acquisition Barrons.com
06:27AM	Coronavirus tally: FDA advisory panel to meet June 15 to discuss Pfizer, BioNTech and Moderna vaccines for children aged 6 months to 4 years MarketWatch
May-23-22 05:05PM	Why Moderna and Pfizer Stocks Lagged the Market Today Motley Fool
04:38PM	Baby formula shortage: Operation Fly Formula brings first imported shipment to Indianapolis Yahoo Finance Video
04:05PM	Pfizer, BioNTech Say Three-Dose Covid Vaccine Is 80% Effective In Children Under 5 Investor's Business Daily
03:15PM	Is Pfizer Stock A Buy After Its Pediatric Covid Shot Proves 80% Effective? Investor's Business Daily
03:13PM	COVID SCIENCE-Omicron breakthrough infections may spare young hearts; no need to delay mammogram after vaccination Reuters
10:49AM	UPDATE 1-Pfizer/BioNTech say 3 COVID shots elicit good response in children under 5 Reuters
10:10AM	UPDATE 1-U.S. FDA sets June meeting dates for Moderna, Pfizer small children COVID-19 vaccines Reuters
09:56AM	Pfizer says 3rd COVID shot for kids under 5 is 80% effective Yahoo Finance Video
09:20AM	10 Best Dividend Stocks to Buy According to Noam Gottesmans GLG Partners Insider Monkey
08:43AM	Pfizers Three-Dose Covid Vaccine Is 80% Effective in Young Children, Data Show Barrons.com
07:46AM	UPDATE 2-Biohaven's drug for neurological disease fails late-stage study Reuters
07:00AM	Pfizer touts vaccine data for children under 5 years old MarketWatch
06:56AM	Pfizer, BioNTech COVID-19 vaccine for children aged 6 months to 5 years meets EUA criteria MarketWatch
06:45AM	Pfizer to seek US emergency approval of Covid vaccine for under 5s Financial Times
06:45AM	Pfizer-BioNTech COVID-19 Vaccine Demonstrates Strong Immune Response, High Efficacy and Favorable Safety in Children 6 Months to Under 5 Years of Age Following Third Dose Business Wire
06:45AM	Pfizer/BioNTech say 3 COVID shots generate good response in under-5s Reuters
06:45AM	Pfizer Announces Positive Data on Three-Dose Covid Vaccine Series for Young Kids Barrons.com
02:51AM	UPDATE 1-AstraZeneca says EU regulator approves COVID shot as booster Reuters
May-22-22 10:33AM	Is There An Opportunity With Pfizer Inc.'s (NYSE:PFE) 50% Undervaluation? Simply Wall St.
06:00AM	Have $2,000? 2 Market Crash-Ready Stocks to Buy Motley Fool
May-20-22 03:58PM	I chose to take a gamble: Husband-wife lab researchers admit taking Pfizer vaccine data to develop their own cancer treatment MarketWatch
12:36PM	Rite Aid and its Bartell Drugs has COVID-19 boosters for 5-to-11 year olds available MarketWatch
12:01PM	Why Pfizer Stock Is Rising Today While Moderna and Novavax Are Sliding Motley Fool
10:50AM	Best Healthcare Stocks To Buy In May FX Empire
08:50AM	Pharma Stock Roundup: FDA Nod to PFE COVID Jab for Age 5-11 & LLY's Tirzepatide Zacks
07:43AM	CDC Recommends Pfizer/BioNTech COVID-19 Booster Shots For Kids Aged 5-11 Years Benzinga
07:00AM	Five Leading Stocks That At Least Double The S&P 500's Yield Investor's Business Daily
06:45AM	5 Oversold Blue-Chip Stocks to Buy Right Now InvestorPlace
06:24AM	Coronavirus tally: Daily COVID-19 cases tops 100,000 again and hospitalizations rise, but deaths fall to 10-mo. low MarketWatch
05:23AM	Pfizer Covid Booster for Kids Aged 5 to 11 Cleared by CDC Barrons.com
May-19-22 05:00PM	CDC Advisors Backs Pfizer Covid Booster for 5- to 11-Year-Olds Barrons.com
04:11PM	UPDATE 4-U.S. CDC backs COVID boosters for children 5 to 11 Reuters
03:44PM	Pfizer, NIH Mulling Study For Longer Paxlovid Course To Combat Reinfections Benzinga
03:41PM	Read Why Pfizer Is Limiting Supply Of Paxlovid For Combination Studies: Bloomberg Benzinga
03:02PM	Enanta's (ENTA) RSV Drug Fails to Meet Study Goal, Stock Drops Zacks
11:37AM	UPDATE 1-EU health regulator backs using AstraZeneca COVID shot as booster Reuters
06:20AM	Should You Invest in the Fidelity MSCI Health Care Index ETF (FHLC)? Zacks
May-18-22 12:21PM	REFILE-U.S. to study whether longer Paxlovid course needed to combat reinfections Reuters
11:53AM	Why Pfizer Looks Better Than Moderna as a Long-Term Buy Motley Fool
10:10AM	Moderna (MRNA) Stock Rises 4%: What's Behind the Upside? Zacks
10:07AM	Pfizer (PFE) Gets EUA for Use of Comirnaty Booster in Children Zacks
09:39AM	10 Best Vanguard Dividend Stocks with High Yields Insider Monkey
06:30AM	Is Ocugen Finally on the Way to Vaccine Revenue? Motley Fool
02:56AM	From storage to transport, hurdles to getting COVID vaccine to N.Koreans Reuters
May-17-22 04:01PM	Pfizer Retakes A Key Line And Drags BioNTech, Moderna With It Investor's Business Daily
04:00PM	FDA Gives Green Signal To Pfizer/BioNTech's COVID-19 Booster For Kids 5-11 Years Benzinga
03:52PM	Why BioNTech Stock Jumped Today Motley Fool
03:41PM	Citi stock up after Berkshire discloses $3 billion stake, FDA approves Pfizer booster for ages 5-11 Yahoo Finance Video
02:55PM	UPDATE 3-As U.S. COVID-19 cases rise, so does demand for antivirals Reuters
11:40AM	Pfizer and BioNTech Granted U.S. Emergency Use Authorization for Booster Dose of Their COVID-19 Vaccine in Children 5 Through 11 Years of Age Business Wire
11:27AM	The Zacks Analyst Blog Highlights NVIDIA, The Home Depot, Pfizer, The Walt Disney, and Salesforce Zacks
11:15AM	U.S. government is offering free COVID tests again, as cases rise 57% from two weeks ago; FDA authorizes booster for children aged 5 to 11 MarketWatch
11:08AM	FDA authorizes a booster dose of BioNTech/Pfizer's vaccine for 5 to 11 year olds MarketWatch
10:57AM	FDA Clears Pfizer Covid Booster for Kids Aged 5 to 11 Barrons.com
10:55AM	Pfizer, BioNTech Rise After FDA Approves Covid Boosters for Children Investing.com
10:24AM	UPDATE 3-U.S. FDA authorizes Pfizer's COVID booster shot for young children Reuters
10:17AM	U.S. FDA authorizes Pfizer's COVID booster shot for young children Reuters
08:45AM	Pfizer's Setbacks With Paxlovid Are Mounting -- Should Investors Be Concerned? Motley Fool
07:26AM	FDA May Authorize Pfizer-BioNTech's COVID-19 Booster For 5-11 Year Kids Soon: NYT Benzinga
May-16-22 04:30PM	UPDATE 3-FDA to soon authorize Pfizer's COVID booster shot for younger kids - NYT Reuters
04:26PM	Is AbbVie Stock A Buy As Humira Biosimilar Rivals Loom? Investor's Business Daily
03:37PM	What you hear in DC doesn't reflect what's going across the US: Fmr. US Surgeon General Yahoo Finance
02:53PM	Top Analyst Reports for NVIDIA, Home Depot, Pfizer & Others Zacks
07:34AM	Pfizer/BioNTech COVID-19 Vaccine's European Delivery Takes Backseat To Help Booster Campaign Benzinga
07:00AM	This Fund Rarely Rebalances But It's Clobbering The Market Investor's Business Daily
May-14-22 10:30AM	3 Supercharged Dividend Stocks to Buy in the Stock Market Sell-Off Motley Fool
07:04AM	3 Dirt-Cheap Stocks You Can Buy Right Now Motley Fool
May-13-22 05:37PM	UPDATE 1-Pfizer, EU push back COVID vaccine delivery to help booster campaign Reuters
02:08PM	Biden Says US Ready To Share COVID-19 Vaccine Related Technology Benzinga
01:44PM	Stock rebound uncertain for U.S. biotechs as risks multiply for investors American City Business Journals
10:41AM	Some patients and physicians say its hard to find Paxlovid, Pfizers COVID-19 pill MarketWatch
08:10AM	Pharma Stock Roundup: PFE's Biohaven Buyout Offer, BAYRY's Q1 Earnings Update Zacks
07:00AM	7 Cheap Stocks to Buy Now for a Rich Retirement InvestorPlace
May-12-22 04:56PM	Pfizer Turns to Unusual Deal Structure to Buy Biohaven Drugs Bloomberg
03:41PM	Price Of Pfizer's Paxlovid Generic Version Capped At $25 Or Less For Low-Income Countries Benzinga
03:09PM	Misinformation Proliferates Surrounding Pfizer Vaccine Investopedia
10:25AM	A Healthcare Revolution Is Coming. How to Invest. Barrons.com
10:00AM	Generic drugmakers to sell Pfizer's Paxlovid for $25 or less in low-income countries Reuters
10:00AM	Astellas Highlights Data on Advanced and Rare Cancers during 2022 ASCO Annual Meeting and EHA 2022 Hybrid Congress PR Newswire
08:02AM	Lilly's (LLY) Olumiant Gets Full Approval From FDA for COVID Zacks
02:45AM	A Healthcare Revolution Is Coming. Heres How to Invest. Barrons.com
May-11-22 02:12PM	Biohaven (BHVN) Up on PFE's Buyout Offer, Q1 Loss Wider Zacks
02:08PM	Exelixis (EXEL) Q1 Earnings Beat, Revenues Miss Estimates Zacks
01:16PM	Pfizer's $11.6 billion Biohaven buy could spark more biotech deals Reuters
01:12PM	Pfizer's $11.6 bln Biohaven buy could spark more biotech deals Reuters

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
DAMICO JENNIFER B.	SVP & Controller	May 16	Sale	50.50	4,000	202,000	15,064	May 17 07:48 AM
SAHNI PAYAL	Executive Vice President	May 13	Sale	49.84	1,408	70,175	17,372	May 16 09:23 PM
Carapezzi William R JR	Executive Vice President	May 12	Sale	50.00	32,908	1,645,400	38,146	May 13 05:38 PM
LANKLER DOUGLAS M	Executive Vice President	May 12	Sale	49.41	38,273	1,891,069	78,803	May 13 05:19 PM
Dolsten Mikael	President R&D	May 11	Sale	49.32	63,902	3,151,547	333,342	May 12 04:34 PM
Dolsten Mikael	President R&D	Mar 03	Option Exercise	31.83	102,460	3,261,036	396,578	Mar 04 04:13 PM
DAMICO JENNIFER B.	SVP & Controller	Feb 26	Option Exercise	25.60	9,713	248,653	26,120	Mar 01 04:02 PM
LANKLER DOUGLAS M	Executive Vice President	Feb 26	Option Exercise	25.60	77,709	1,989,350	174,507	Mar 01 04:03 PM
McDermott Michael	Executive Vice President	Feb 26	Option Exercise	25.60	12,340	315,904	83,530	Mar 01 04:03 PM
Carapezzi William R JR	Executive Vice President	Feb 26	Option Exercise	25.60	21,193	542,541	87,363	Mar 01 04:03 PM
DAMELIO FRANK A	Executive Vice President	Feb 26	Option Exercise	25.60	127,160	3,255,296	649,918	Mar 01 05:55 PM
SUSMAN SALLY	Executive Vice President	Feb 26	Option Exercise	25.60	63,580	1,627,648	172,880	Mar 01 05:55 PM
SAHNI PAYAL	Executive Vice President	Feb 23	Option Exercise	27.34	13,884	379,589	29,391	Feb 25 06:27 PM
SUSMAN SALLY	Executive Vice President	Feb 23	Option Exercise	27.34	76,895	2,102,309	166,470	Feb 25 06:29 PM
Hwang Angela	Group President	Feb 23	Option Exercise	27.34	21,359	583,955	21,359	Feb 25 06:10 PM
LANKLER DOUGLAS M	Executive Vice President	Feb 23	Option Exercise	27.34	115,342	3,153,450	181,659	Feb 25 06:20 PM
DAMELIO FRANK A	Executive Vice President	Feb 23	Option Exercise	27.34	153,789	4,204,591	636,977	Feb 25 06:04 PM
JOHNSON RADY A	Executive Vice President	Feb 23	Option Exercise	27.34	35,457	969,394	91,301	Feb 25 06:17 PM
DAMICO JENNIFER B.	SVP & Controller	Feb 23	Option Exercise	27.34	11,748	321,190	21,668	Feb 25 05:46 PM
Carapezzi William R JR	Executive Vice President	Feb 23	Option Exercise	27.34	25,632	700,779	82,914	Feb 25 05:06 PM
Dolsten Mikael	President R&D	Dec 17	Option Exercise	30.17	71,187	2,147,712	351,637	Dec 21 06:31 PM
BOURLA ALBERT	Chairman & CEO	Dec 17	Option Exercise	26.73	123,055	3,289,547	246,444	Dec 21 06:03 PM
JOHNSON RADY A	Executive Vice President	Dec 03	Sale	53.42	19,000	1,015,042	55,844	Dec 06 05:18 PM
MACKENZIE ALEXANDER R	Executive Vice President	Dec 02	Sale	54.26	41,360	2,244,194	87,280	Dec 06 05:18 PM
SUSMAN SALLY	Executive Vice President	Nov 26	Sale	54.52	44,308	2,415,578	89,575	Nov 30 04:30 PM
LANKLER DOUGLAS M	Executive Vice President	Nov 26	Sale	54.37	40,000	2,174,786	66,317	Nov 30 04:30 PM
Hwang Angela	Group President	Nov 12	Sale	49.60	26,170	1,298,002	1	Nov 15 05:32 PM
Dolsten Mikael	President R&D	Nov 11	Option Exercise	25.13	199,548	5,014,926	339,506	Nov 15 05:40 PM
Dolsten Mikael	President R&D	Nov 11	Sale	50.29	59,664	3,000,647	279,842	Nov 15 05:40 PM
YOUNG JOHN D	Group President	Nov 11	Sale	50.06	150,000	7,508,732	312,704	Nov 12 06:08 PM
DAMICO JENNIFER B.	SVP & Controller	Aug 13	Sale	48.30	1,661	80,226	9,769	Aug 16 08:12 PM
DAMICO JENNIFER B.	SVP & Controller	Jul 30	Sale	42.86	2,500	107,150	11,430	Aug 02 07:02 PM

open in yahoo | open in reuters | open in marketwatch | open in google

Upgrade your FINVIZ experience